FineMark National Bank & Trust Sells 2,471 Shares of Danaher Co. (NYSE:DHR)

FineMark National Bank & Trust lessened its position in Danaher Co. (NYSE:DHR - Free Report) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 77,010 shares of the conglomerate's stock after selling 2,471 shares during the period. FineMark National Bank & Trust's holdings in Danaher were worth $17,678,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in DHR. Gilbert & Cook Inc. boosted its stake in Danaher by 2.5% during the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate's stock worth $401,000 after acquiring an additional 42 shares in the last quarter. Grimes & Company Inc. raised its holdings in shares of Danaher by 0.6% during the fourth quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate's stock valued at $1,696,000 after purchasing an additional 43 shares during the period. Dakota Community Bank & Trust NA boosted its position in shares of Danaher by 16.4% during the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate's stock worth $73,000 after purchasing an additional 45 shares in the last quarter. Howard Capital Management Group LLC grew its stake in shares of Danaher by 4.1% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate's stock valued at $342,000 after buying an additional 48 shares during the period. Finally, Spinnaker Trust increased its position in Danaher by 1.2% in the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate's stock valued at $988,000 after buying an additional 50 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Remove Ads

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on DHR. Barclays cut their price target on Danaher from $275.00 to $240.00 and set an "equal weight" rating on the stock in a report on Thursday, January 30th. Guggenheim started coverage on shares of Danaher in a research report on Thursday, December 19th. They issued a "buy" rating and a $275.00 price target for the company. Stifel Nicolaus upgraded shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective on the stock in a report on Friday, March 14th. JPMorgan Chase & Co. cut their target price on Danaher from $310.00 to $300.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Finally, Citigroup cut their price objective on shares of Danaher from $285.00 to $265.00 and set a "buy" rating on the stock in a report on Thursday, January 30th. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $278.24.

Danaher Stock Performance

Shares of NYSE DHR traded down $4.43 during trading on Friday, reaching $205.69. 2,388,883 shares of the stock traded hands, compared to its average volume of 3,186,485. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a market capitalization of $147.01 billion, a P/E ratio of 38.96, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a 50-day moving average of $214.57 and a 200-day moving average of $236.64.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the firm earned $2.09 EPS. Analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This is a boost from Danaher's previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.62%. Danaher's payout ratio is presently 24.24%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.